Why is YouTube TV adding ESPN Unlimited for free?
How did Peter Thiel's stock sales affect market sentiment?
Why is Japan's economy contracting despite tariff relief?
What impact will FAA lifting flight cuts have on airlines?
How did immigration raids in Charlotte affect local businesses?
Why are Chinese shoppers favoring local luxury over foreign brands?
What caused Tata Motors' losses from the Jaguar Land Rover hack?
Novartis' Investigational Medicine Shows Potent Activity Against Drug-Resistant Malaria Strains
benzinga.com/news/health-care/25/11/48842681/novartis-investigational-medicine-shows-potent-activity-against-drug-resistant-malaria-strains
Novartis AG (NYSE:NVS) released data on Thursday from the KALUMA Phase 3 study for the new malaria treatment KLU156 (ganaplacide/lumefantrine, or GanLum).
GanLum is a combination of two compounds: ganaplacide, a novel compound with an entirely new mechanism of action, and a new once-daily…
This story appeared on benzinga.com, 2025-11-13 17:33:20.